Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Osheroff

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|September 5, 1985
Purification and characterization of a periplasmic oligopeptide binding protein from Escherichia coliC A Guyer, D G Morgan, N Osheroff, et al.
The Journal of Biological Chemistry|June 23, 1995
Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopyS J Froelich-Ammon, M W Patchan, N Osheroff, et al.
Biochemistry|July 25, 1989
Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediateE L Zechiedrich, K Christiansen, A H Andersen, et al.
Cancer Research|August 17, 2000
Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103J Kluza, A Lansiaux, N Wattez, et al.
Brain Research. Molecular Brain Research|September 1, 1994
Inhibition of protein kinase C- and casein kinase II-mediated phosphorylation of GAP-43 by S100 betaL H Lin, L J Van Eldik, N Osheroff, et al.
The Journal of Biological Chemistry|December 25, 1979
Site-specific anti-cytochrome c antibodies. Inhibition of the reactions between cytochrome c and its respiratory chain electron exchange partnersN Osheroff, R Jemmerson, S H Speck, et al.
The Journal of Biological Chemistry|October 24, 1998
A mutant yeast topoisomerase II (top2G437S) with differential sensitivity to anticancer drugs in the presence and absence of ATPM Sabourin, J A Byl, S E Hannah, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1993
Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potentialS H Elsea, P R McGuirk, T D Gootz, et al.
Biochemistry|March 11, 1997
Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugsS H Elsea, M Westergaard, D A Burden, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine groupM J Robinson, B A Martin, T D Gootz, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|September 5, 1985
Purification and characterization of a periplasmic oligopeptide binding protein from Escherichia coliC A Guyer, D G Morgan, N Osheroff, et al.
The Journal of Biological Chemistry|June 23, 1995
Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopyS J Froelich-Ammon, M W Patchan, N Osheroff, et al.
Biochemistry|July 25, 1989
Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediateE L Zechiedrich, K Christiansen, A H Andersen, et al.
Cancer Research|August 17, 2000
Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103J Kluza, A Lansiaux, N Wattez, et al.
Brain Research. Molecular Brain Research|September 1, 1994
Inhibition of protein kinase C- and casein kinase II-mediated phosphorylation of GAP-43 by S100 betaL H Lin, L J Van Eldik, N Osheroff, et al.
The Journal of Biological Chemistry|December 25, 1979
Site-specific anti-cytochrome c antibodies. Inhibition of the reactions between cytochrome c and its respiratory chain electron exchange partnersN Osheroff, R Jemmerson, S H Speck, et al.
The Journal of Biological Chemistry|October 24, 1998
A mutant yeast topoisomerase II (top2G437S) with differential sensitivity to anticancer drugs in the presence and absence of ATPM Sabourin, J A Byl, S E Hannah, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1993
Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potentialS H Elsea, P R McGuirk, T D Gootz, et al.
Biochemistry|March 11, 1997
Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugsS H Elsea, M Westergaard, D A Burden, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine groupM J Robinson, B A Martin, T D Gootz, et al.
Pageof 11